A patent on breast cancer genes? Yes, says court
A U.S. federal appeals court has affirmed the right of Myriad Genetics to patent two human genes that form the basis of a widely used genetic test for breast and ovarian cancers. Opponents argued that it’s immoral and unethical to patent human DNA.
